'Adverse event rates' diaporamas de présentation

Influenza 2013 - 2014

439 views • 36 slides

Regulation of Schedule II Medications

Regulation of Schedule II Medications. Michael A. Berry, M.D., M.S. Manager, Medical Specialties Division Office of Aerospace Medicine Federal Aviation Administration Washington, DC. Presented to: Federal Motor Carrier Safety Advisory Committee Tuesday, Sept. 10, 2013. Outline.

425 views • 36 slides

Relationship between hospital safety climate and outcomes

Relationship between hospital safety climate and outcomes. Sara Singer, Alyson Falwell, Shoutzu Lin, Toby Rathgeb, Laurence Baker AcademyHealth Annual Meeting June 26, 2006

334 views • 24 slides

Atorvastatin Versus Revascularization Treatments (AVERT) Trial

AVERT Trial. Atorvastatin Versus Revascularization Treatments (AVERT) Trial. Presented at The American Heart Association Scientific Sessions 1998 Presented by Dr. Bertram Pitt. AVERT Trial: Background.

503 views • 17 slides

The Shang Ring vs Conventional Surgical Techniques: an RCT in Kenya and Zambia

The Shang Ring vs Conventional Surgical Techniques: an RCT in Kenya and Zambia. Session TUAC04 Male Circumcision: Strategies and Impact AIDS 2012: Tuesday, July 24. Dr. Quentin Awori. Shang Ring Procedure. Shang Ring Circumcision. 2. Place inner ring. 3. Evert foreskin.

892 views • 17 slides

CDRH Advisory Committee Meeting: Orthopedic and Rehabilitation Devices Panel

179 views • 7 slides

Figure 1 The relationship between sodium status and adverse event rates during RAAS blockade

Figure 1 The relationship between sodium status and adverse event rates during RAAS blockade. Lambers Heerspink, H. J. et al . (2012) Improving the efficacy of RAAS blockade in patients with chronic kidney disease Nat. Rev. Nephrol. doi:10.1038/nrneph.2012.281.

152 views • 1 slides